Clinical trial
Optimal Dose of Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery
NCT05069012 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Dose of Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 15, 2021
- Completion date
- July 23, 2022
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.